Abstract
Recent advances in molecular biology have led to a better understanding of the etiology of vestibular schwannomas. The underlying purpose of vestibular schwannoma research is the development of new treatment options; however, such options have not yet been established. A fundamental understanding of the underlying molecular events leading to tumor formation began when mutations in the neurofibromatosis type 2 (NF2) tumor suppressor gene were identified in vestibular schwannomas. The clinical characteristics of vestibular schwannomas and neurofibromatosis type 2 (NF2) syndromes have both been related to alterations in the NF2 gene. Genetic screening for NF2 is now available. When utilized with clinical screening, such as magnetic resonance imaging (MRI), conventional audiometry, and auditory brainstem response (ABR), the early detection of NF2 can be made, which consequently makes a significant difference in the ability to successfully treat vestibular schwannomas. Additionally, the signaling pathways affected by merlin, the product of the NF2 gene, are becoming better understood. Nf2-transgenic and knockout mice as well as vestibular schwannoma xenograft models are now ready for novel therapeutic testing. Hopefully, better treatment options will be forthcoming soon.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Neff, B. A., Welling, D. B., Akhmametyeva, E., and Chang, L. S. (2006) The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level. Otol. Neurotol. 27, 197–208.
Welling, D. B., Packer, M. D., and Chang, L.-S. (2007) Molecular studies of vestibular schwannomas: a review. Curr. Opin. Otolaryngol. Head Neck Surg. 15, 341–346.
Rouleau, G. A., Merel, P., Lutchman, M., et al. (1993) Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2. Nature 363, 515–521.
Trofatter, J. A., MacCollin, M. M., Rutter, J. L., et al. 1993. A novel Moesin-, Exrin-, Radixin-like gene is a candidate for the neurofibromatosis 2 tumor-suppressor. Cell 72, 791–800.
Jacoby, L. B., MacCollin, M., Louis, D. N., Mohney, T., et al. 1994. Exon scanning for mutation of the NF2 gene in schwannomas. Hum. Mol. Genet. 3, 413–419.
Welling, D. B., Guida, M., Goll, F., Pearl, D. K., et al. (1996) Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas. Human Genet. 98, 189–193.
D. B., Lasak, J. M., Akhmametyeva, E., Ghaheri, B., and Chang, L.-S. (2002) cDNA microarray analysis of vestibular schwannomas. Otol. Neurotol. 23, 736–748.
Baser M. E. (2006) Contributors to the International NF2 Mutation Database. 2006. The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene. Human Mutat. 27, 297–306.
McClatchey, A. I. and Giovannini, M. 2005. Membrane organization and tumorigenesis – the NF2 tumor suppressor, Merlin. Genes Dev. 19, 2265–2277.
Okada, T., You, L., and Giancotti, F. G. (2007) Shedding light on Merlin’s wizardry. Trends Cell Biol. 17, 222–229.
Welling, D. B., Glasscock, M. E., Woods, C. I., and Jackson, C. G. (1990) Acoustic neuroma: A cost-effective approach. Otolaryngol. HN Surg. 103, 364–370.
Schmalbrock, P., Chakeres, D. W., Monroe, J. W., Saraswat, A., Miles, B. A., and Welling, D. B. (1999) Assessment of internal auditory canal tumors: a comparison of contrast-enhanced T1-weighted and steady-state T2-weighted gradient-echo MR imaging. Am. J. Neuroradiol. 20, 1207–1213.
Lasak, J. M., Welling, D. B., Akhmametyeva, E. M., Salloum, M., and Chang, L.-S. (2002) Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas. Laryngoscope 112, 1555–1561.
Jacob, A., Lee, T. X., Neff, B. A., Miller, S., Welling, B., and Chang, L. S. (2008) Phosphatidylinositol 3-Kinase/AKT pathway activation in human vestibular schwannomas. Otol. Neurotol. 29: 58–68.
Giovannini, M., Robanus-Maandag, E., Niwa-Kawakita, M., van der Valk, M., et al. (1999) Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev. 13, 978–986.
Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., et al. (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 14, 1617–1630.
Chang, L. S., Jacob, A., Lorenz, M., Rock, J., et al. (2006) Growth of benign and malignant schwannoma xenografts in severe combined immunodeficiency mice. Laryngoscope 116, 2018–2026.
Check, E. (2007) Cancer atlas maps out sample worries. Nature 447, 1036–1037.
Zucman-Rossi, J., Legoix, P., Der Sarkissian, H., Cheret, G., Sor, F., Bernardi, A., Cazes, L., Giraud, S., Ollagnon, E., Lenoir, G., and Thomas G. (1998) NF2 gene in neurofibromatosis type 2 patients. Hum. Mol. Genet. 7, 2095–2101.
Chang, L.-S., Akhmametyeva, E. M., Wu, Y., Zhu, L., and Welling, D. B. (2002) Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts. Genomics 79, 63–76.
Morrissey, T. K., Kleitman, N., and Bunge, R. P. (1991). Isolation and functional characterization of Schwann cells derived from adult peripheral nerve. J. Neurosci. 11, 2433–2442.
Casella, G. T., Bunge, R. P., and Wood, P. M. (1996) Improved method for harvesting human Schwann cells from mature peripheral nerve and expansion in vitro. Glia 17, 327–338.
Mauritz, C., Grothe, C., and Haastert, K. (2004) Comparative study of cell culture and purification methods to obtain highly enriched cultures of proliferating adult rat Schwann cells. J. Neurosci. Res. 77, 453–461.
Haastert, K., Mauritz, C., Matthies, C., and Grothe, C. (2006) Autologous adult human Schwann cells genetically modified to provide alternative cellular transplants in peripheral nerve regeneration. J. Neurosurg. 104, 778–786.
Haastert, K., Mauritz, C., Chaturvedi, S., and Grothe, C. (2007) Human and rat adult Schwann cell cultures: fast and efficient enrichment and highly effective non-viral transfection protocol. Nat. Protoc. 2, 99–104.
Shultz, L. D., Ishikawa, F., and Greiner, D. L. (2007) Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7, 118–130.
Lee, J. K., Sobel, R. A., Chiocca, E. A., Kim, T. S., and Martuza, R. L. (1992) Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse. J. Neurooncol. 14, 101–112.
Charabi, S., Rygaard, J., Klinken, L., Tos, M., and Thomsen, J. (1994) Subcutaneous growth of human acoustic schwannomas in athymic nude mice. Acta Otolaryngol. 114, 399–405.
Stidham, K. R. and Roberson, J. B., Jr. (1997) Human vestibular schwannoma growth in the nude mouse: evaluation of a modified subcutaneous implantation model. Am. J. Otol. 18, 622–626.
Ferrer, I., Armstrong, J., Capellari, S., Parchi, P., et al. (2007) Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study. Brain Pathol. 17, 297–303.
Szijan, I., Rochefort, D., Bruder, C., Surace, E., et al. (2003) NF2 Tumor suppressor gene: A comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH. NeuroMol. Med. 3, 41–52.
Wallace, A. J., Watson, C. J., Oward, E., Evans, D. G. R., and Elles, R. G. (2004) Mutation scanning of the NF2 gene: An improved service based on Meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis. Genet. Testing 8, 368–380.
Kluwe, L., Nygren, A. O. H., Errami, A., Heinrich, B., Matthies, C., Tatagiba, M., and Mautner, V. (2005) Screening for Large Mutations of the NF2 Gene. Genes Chrom. Cancer 42, 384–391.
Casella, G. T., Wieser, R., Bunge, R. P., Margitich, I. S., Katz, J., Olson, L., and Wood, P. M. (2000) Density dependent regulation of human Schwann cell proliferation. Glia 30, 165–177.
Manent, J., Oguievetskaia, K., Bayer, J., Ratner, N., and Giovannini, M. (2003) Magnetic cell sorting for enriching Schwann cells from adult mouse peripheral nerves. J. Neurosci. Methods 123, 167–173.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Chang, LS., Welling, D.B. (2009). Molecular Biology of Vestibular Schwannomas. In: Sokolowski, B. (eds) Auditory and Vestibular Research. Methods in Molecular Biology™, vol 493. Humana Press. https://doi.org/10.1007/978-1-59745-523-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-59745-523-7_10
Publisher Name: Humana Press
Print ISBN: 978-1-934115-62-6
Online ISBN: 978-1-59745-523-7
eBook Packages: Springer Protocols